ATP6V0E1

Insilico Medicine Identifies Alzheimer’s Targets Using AI

Hong Kong, September 1, 2026 Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI), has announced...

By cGxPwire Editor
September 4, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

ATP6V0E1

Insilico Medicine Identifies Alzheimer’s Targets Using AI